A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma
Clinical trial NCT02504099 · TERMINATED
Trial details
- NCT number
- NCT02504099
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-09-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.